Home > Neurology > EAN 2022 > COVID-19 > COVID-19 elevates risk of neurodegenerative disorders

COVID-19 elevates risk of neurodegenerative disorders

Presented By
Dr Pardis Zarifkar, Rigshospitalet, Denmark
EAN 2022
COVID-19-positive outpatients had an increased risk of a broad range of neurodegenerative and cerebrovascular disorders compared with participants who tested negative. However, no excess risk was detected compared with influenza A/B and community-acquired pneumonia, except for ischaemic stroke. More than 2 years after the onset of the COVID-19 pandemic, the precise nature and evolution of the effects of COVID-19 on neurological disorders are still not characterised. Previous studies have established an association with neurological syndromes, but it is still unknown whether COVID-19 influences the incidence of specific neurological diseases and whether it differs from other respiratory infections [1,2]. Dr Pardis Zarifkar (Rigshospitalet, Denmark) and her group utilised electronic health records of 2,972,192 patients, which is about half of Denmark’s population, to characterise the influence of COVID-19 on neurological diseases [3,4]. Included we...

Please login to read the full text of the article.

If you have no account yet, please register now.

Posted on